Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells

S. F. Hackett, Peter A Campochiaro

Research output: Contribution to journalArticle

Abstract

Purpose. To examine the effect of several agents that either stimulate or inhibit neovascularization on plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells and vascular endothelial cells. Methods. Steady-state levels of messenger RNA were assessed by Northern blots and dot blots and protein levels were assessed by immunoprecipitation. Results. Data indicate that messenger RNA levels for plasminogen activator inhibitor-1 are modulated in similar fashion in both cells types, being increased by incubation with transforming growth factor-beta, dexamethasone, tumor necrosis factor, phorbol myristate acetate, and thrombin. Levels of urokinase messenger RNA in retinal pigmented epithelial cells are significantly increased only by phorbol myristate acetate and are decreased by dexamethasone and transforming growth factor-beta, whereas in endothelial cells plasminogen activator urokinase messenger RNA is increased by each of the stimuli except dexamethasone, which causes a decrease. Immunoprecipitation experiments demonstrate similar modulation of inhibitor- 1 proteins secreted by retinal pigmented epithelial cells, whereas urokinase is difficult to detect. Conclusions. These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization.

Original languageEnglish (US)
Pages (from-to)2055-2061
Number of pages7
JournalInvestigative Ophthalmology and Visual Science
Volume34
Issue number6
StatePublished - 1993

Fingerprint

Plasminogen Activator Inhibitor 1
Urokinase-Type Plasminogen Activator
Epithelial Cells
Dexamethasone
Messenger RNA
Endothelial Cells
Tetradecanoylphorbol Acetate
Immunoprecipitation
Transforming Growth Factor beta
Choroidal Neovascularization
Plasminogen Activators
Thrombin
Northern Blotting
Proteins
Tumor Necrosis Factor-alpha

Keywords

  • Choroidal neovascularization
  • plasminogen activator inhibitors
  • retinal pigmented epithelium
  • urokinase
  • vascular endothelium

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells. / Hackett, S. F.; Campochiaro, Peter A.

In: Investigative Ophthalmology and Visual Science, Vol. 34, No. 6, 1993, p. 2055-2061.

Research output: Contribution to journalArticle

@article{dd33dd74c8c24351a280e470f91cd3f5,
title = "Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells",
abstract = "Purpose. To examine the effect of several agents that either stimulate or inhibit neovascularization on plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells and vascular endothelial cells. Methods. Steady-state levels of messenger RNA were assessed by Northern blots and dot blots and protein levels were assessed by immunoprecipitation. Results. Data indicate that messenger RNA levels for plasminogen activator inhibitor-1 are modulated in similar fashion in both cells types, being increased by incubation with transforming growth factor-beta, dexamethasone, tumor necrosis factor, phorbol myristate acetate, and thrombin. Levels of urokinase messenger RNA in retinal pigmented epithelial cells are significantly increased only by phorbol myristate acetate and are decreased by dexamethasone and transforming growth factor-beta, whereas in endothelial cells plasminogen activator urokinase messenger RNA is increased by each of the stimuli except dexamethasone, which causes a decrease. Immunoprecipitation experiments demonstrate similar modulation of inhibitor- 1 proteins secreted by retinal pigmented epithelial cells, whereas urokinase is difficult to detect. Conclusions. These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization.",
keywords = "Choroidal neovascularization, plasminogen activator inhibitors, retinal pigmented epithelium, urokinase, vascular endothelium",
author = "Hackett, {S. F.} and Campochiaro, {Peter A}",
year = "1993",
language = "English (US)",
volume = "34",
pages = "2055--2061",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "6",

}

TY - JOUR

T1 - Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells

AU - Hackett, S. F.

AU - Campochiaro, Peter A

PY - 1993

Y1 - 1993

N2 - Purpose. To examine the effect of several agents that either stimulate or inhibit neovascularization on plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells and vascular endothelial cells. Methods. Steady-state levels of messenger RNA were assessed by Northern blots and dot blots and protein levels were assessed by immunoprecipitation. Results. Data indicate that messenger RNA levels for plasminogen activator inhibitor-1 are modulated in similar fashion in both cells types, being increased by incubation with transforming growth factor-beta, dexamethasone, tumor necrosis factor, phorbol myristate acetate, and thrombin. Levels of urokinase messenger RNA in retinal pigmented epithelial cells are significantly increased only by phorbol myristate acetate and are decreased by dexamethasone and transforming growth factor-beta, whereas in endothelial cells plasminogen activator urokinase messenger RNA is increased by each of the stimuli except dexamethasone, which causes a decrease. Immunoprecipitation experiments demonstrate similar modulation of inhibitor- 1 proteins secreted by retinal pigmented epithelial cells, whereas urokinase is difficult to detect. Conclusions. These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization.

AB - Purpose. To examine the effect of several agents that either stimulate or inhibit neovascularization on plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells and vascular endothelial cells. Methods. Steady-state levels of messenger RNA were assessed by Northern blots and dot blots and protein levels were assessed by immunoprecipitation. Results. Data indicate that messenger RNA levels for plasminogen activator inhibitor-1 are modulated in similar fashion in both cells types, being increased by incubation with transforming growth factor-beta, dexamethasone, tumor necrosis factor, phorbol myristate acetate, and thrombin. Levels of urokinase messenger RNA in retinal pigmented epithelial cells are significantly increased only by phorbol myristate acetate and are decreased by dexamethasone and transforming growth factor-beta, whereas in endothelial cells plasminogen activator urokinase messenger RNA is increased by each of the stimuli except dexamethasone, which causes a decrease. Immunoprecipitation experiments demonstrate similar modulation of inhibitor- 1 proteins secreted by retinal pigmented epithelial cells, whereas urokinase is difficult to detect. Conclusions. These data suggest that retinal pigmented epithelial cells may help to alter proteolytic activity in the subretinal space and thereby participate, along with endothelial cells, in the regulation of choroidal neovascularization.

KW - Choroidal neovascularization

KW - plasminogen activator inhibitors

KW - retinal pigmented epithelium

KW - urokinase

KW - vascular endothelium

UR - http://www.scopus.com/inward/record.url?scp=0027324423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027324423&partnerID=8YFLogxK

M3 - Article

C2 - 8491554

AN - SCOPUS:0027324423

VL - 34

SP - 2055

EP - 2061

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 6

ER -